TREATING CORNEAL EDEMA
HYPER-CL IS A NOVEL SOLUTION FOR TREATING CORNEAL EDEMA

The Hyper-CL contact lens provides a novel solution for treatment of corneal edema. Coupled with hypertonic drops, the lens has been shown to have a dramatic impact on treatment outcome. The lens may be used for daily wear and can be removed for cleaning and disinfection at any time and then reinserted to the eye. Click here to learn more about Hyper-CL.

EyeYon Medical Boxes

Hyper-CL is currently being tested for applying any eye drops
to treat various ocular pathologies, such as:

CATARACT SURGERY

The vast majority of post-cataract-surgery edema cases resolve in a week or less without any treatment. Physicians estimate that 1% of all cataract surgery patients will have corneal edema which reduces visual acuity for longer than one week. 75–80% of these cases will see the edema clear within 2–3 months. Between 20–25% of them will require endothelial or corneal transplantation.

DRY EYE SYNDROME

Dry eye syndrome is a common disorder of the tear film that occurs when tears aren’t able to provide adequate lubrication to the eyes. It affects a significant percentage of the population (up to 30%), especially those older than 50 years of age. Dry eye syndrome can affect patients of any race, and is more common in women than in men. In addition to an imbalance in the tear-flow system of the eye, dry eyes can be caused by situations that dry out the tear film. This can be due to dry air from air conditioning or heat, as a result of aging, and as a side effect of certain drugs.

CORNEAL COLLAGEN CROSS-LINKING

Corneal collagen cross-linking with riboflavin (vitamin B2) and UV-A light is a para-surgical treatment for corneal ectasia such as keratoconus. The cross-linking involves a one-time application of riboflavin solution to the eye that is activated by illumination with UV-A light for approximately 30 minutes. The riboflavin causes new bonds to form across adjacent collagen strands in the stromal layer of the cornea, which recovers and preserves some of the cornea’s mechanical strength.

UVEITIS

Uveitis (also known as iridocyclitis) is the inflammation of the uvea, the pigmented layer that lies between the inner retina and the outer fibrous layer composed of the sclera and cornea. It is an ophthalmic emergency and requires urgent treatment to control the inflammation associated with this condition. Treatment is typically performed with glucocorticoid steroids, either as topical eye drops or as oral therapy. Uveitis affects approximately one in 4,500 people and is most common between the ages 20 to 60, with men and women affected equally. It is estimated to be responsible for approximately 10–20% of the blindness in the United States.

GET IN TOUCH WITH US
OUR OFFICE

Golda Meir 5, floor #2
Nes Ziona 7403649
Israel

Office: info@eye-yon.com
Phone: +972.73.780.3607
Fax: +972.73.780.3608
Mobile: +972.54.545.0506

CONTACT FORM